|
AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
RECRUITINGSponsored by University of Alabama at Birmingham
Actively Recruiting
SponsorUniversity of Alabama at Birmingham
Started2020-09-01
Est. completion2027-03-28
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT04721717
Summary
The UAB Institute for Arts In Medicine (AIM) is currently implementing an expressive emotional writing pilot project for adults with paralysis caused by neurological conditions such as traumatic head or spinal cord injury.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: 1. Age 18 or older with paralysis living in the community 2. limb paralysis resulting from a traumatic event/accident or neurological disease (e.g., spinal cord injury, head injury, stroke, multiple sclerosis, Transverse myelitis, poliomyelitis, peripheral neuropathy, Parkinson's disease, ALS, botulism, and Guillain-Barré syndrome etc) happened after childhood 3. a non-traumatic spinal cord injury may be caused by arthritis, cancer, inflammation, infections or disk degeneration of the spine 4. caregivers of people with amyotrophic lateral sclerosis 5. able to communicate verbally or through writing Exclusion Criteria: 1. known maladaptive behavioral patterns, exhibition of overt psychotic symptoms (e.g., presence of hallucinations, delusions, or thought disorders) 2. congenital (e.g., spinal bifida, cerebral palsy)
Conditions5
Amyotrophic Lateral SclerosisCancerMultiple SclerosisSpinal Cord InjuriesTransverse Myelitis
Locations1 site
354 School of Health Professions Building
Birmingham, Alabama, 35294
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorUniversity of Alabama at Birmingham
Started2020-09-01
Est. completion2027-03-28
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT04721717